Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
569 hedge funds and large institutions have $9.7B invested in Exact Sciences in 2025 Q3 according to their latest regulatory filings, with 78 funds opening new positions, 202 increasing their positions, 182 reducing their positions, and 59 closing their positions.
32% more first-time investments, than exits
New positions opened: 78 | Existing positions closed: 59
29% more call options, than puts
Call options by funds: $133M | Put options by funds: $103M
11% more repeat investments, than reductions
Existing positions increased: 202 | Existing positions reduced: 182
2% more funds holding
Funds holding: 559 → 569 (+10)
2% more capital invested
Capital invested by funds: $9.49B → $9.7B (+$210M)
0.99% less ownership
Funds ownership: 94.64% → 93.65% (-0.99%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$175M |
| 2 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$125M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$113M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$109M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$412M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$334M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$103M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$99M |
| 5 |
Goldman Sachs
New York
|
-$90.3M |
EXAS Hedge Fund Activity: Q3 2025 in Review
569 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2025, worth a combined $9.7B — up 2.2% from $9.49B a quarter earlier.
Buyers outnumbered sellers: 78 funds opened new EXAS positions and 59 closed out — a net gain of 19 holders — while 202 added to existing stakes and 182 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $175M. The largest seller was Fidelity Investments, cutting an estimated $412M.
- 569 institutional investors held Exact Sciences (EXAS) as of Q3 2025, up from 559 in Q2 2025.
- Funds reported $9.7B of Exact Sciences stock for Q3 2025, up 2.2% quarter-over-quarter.
- 78 funds opened new Exact Sciences positions in Q3 2025 and 59 closed out, a net change of +19 holders.
- The largest Exact Sciences buyer in Q3 2025 was Citadel Advisors, an estimated $175M added.
- The largest Exact Sciences seller in Q3 2025 was Fidelity Investments, an estimated $412M sold.
Based on aggregated 13F filings for Q3 2025.